Navigation Links
Michael A. Jacobsen Joining Omeros as Vice President, Finance and Chief Accounting Officer
Date:8/13/2013

SEATTLE, Aug. 13, 2013 /PRNewswire/ -- Omeros Corporation (NASDAQ: OMER), a clinical-stage biopharmaceutical company committed to discovering, developing and commercializing products targeting inflammation, coagulopathies and disorders of the central nervous system, has announced that Michael A. Jacobsen is joining the company as vice president, finance and chief accounting officer.

"Mike's experience leading finance teams responsible for the commercial launch of biopharmaceutical products including Cialis®, one of the most successful drugs on the market, will be instrumental as we anticipate marketing approval for OMS302 next year," stated Gregory A. Demopulos, M.D., Omeros' chairman and chief executive officer. "With his deep background in accounting, business management and finance, I expect that Mike will begin contributing immediately to Omeros' planned transition to a commercial company."

"I am impressed by what the Omeros team has accomplished and by the tremendous potential of Omeros' development programs," said Mr. Jacobsen. "These are exciting times for Omeros, and I look forward to helping the company achieve commercial success for a long line of products, starting with OMS302."

Mr. Jacobsen brings over 30 years of senior business management and accounting experience to Omeros and led the finance teams responsible for the commercial launch of Cialis® and Recothrom®. His experience includes more than a decade of service as a senior finance and accounting officer with publicly traded medical research, drug development and biotechnology companies. Omeros' board of directors will appoint Mr. Jacobsen to his position of vice president, finance and chief accounting officer.

Most recently, Mr. Jacobsen was vice president of finance
'/>"/>

SOURCE Omeros Corporation
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Promising Parkinsons Disease Research Highlighted by The Michael J. Fox Foundation to Accelerate Drug Development
2. NeuroDerm Awarded $1M by The Michael J. Fox Foundation for the Clinical Development of ND0612 for Parkinsons Disease
3. Manhattan NYC Cosmetic Dentist Dr. Michael Wei Providing Invisalign Braces
4. American Skin Association Announces New Member Of The Board J. Michael Pearson And New Education Council Member Ryan Weldon Of Valeant Pharmaceuticals International, Inc.
5. Array BioPharma Names Michael N. Needle, M.D. As Chief Medical Officer
6. Chimerix Appoints Michael D. Rogers, Ph.D., as Chief Development Officer
7. SurgiCount Medical Announces The Appointment Of Michael Roux As Vice President of Product Management
8. The Michael J. Fox Foundation Launches New Funding Opportunities for Parkinsons Research
9. Metabolic Solutions Development Company Awarded Funding by The Michael J. Fox Foundation
10. Raleigh CoolSculpting Complete Provides Twice the Fat Elimination in Just One Hour Now Available at Michael Law MD Aesthetic Plastic Surgery
11. Questcor Pharmaceuticals Appoints Michael Aldridge to the Position of Senior Vice President, Corporate Strategic Development
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/6/2015)... , July 6, 2015 Moerae Matrix, ... novel therapeutics that target inflammation and fibrosis, today ... M.D., PhD, as Chief Medical Officer. ... development strategy and programs, which include a pipeline ... and fibrotic conditions.  Bill is an accomplished strategist ...
(Date:7/6/2015)... , July 6, 2015 Celtaxsys, Inc., a ... including those with rare and orphan inflammatory disease indications, ... U.S. Food and Drug Administration (FDA) to begin a ... acebilustat (CTX-4430), in adult CF patients in the US. ... Europe will be filed soon after. ...
(Date:7/6/2015)... SUNNYVALE, Calif. , July 6, 2015   ... will report financial results for its 2015 second quarter ... after the close of the market. The ... Pacific Time on Thursday, July 23, 2015, to discuss ... Cepheid,s website at http://ir.cepheid.com at least 15 ...
Breaking Medicine Technology:Moerae Matrix, Inc. (Moerae) Appoints Bill Bradford, M.D., PhD, as Chief Medical Officer 2Celtaxsys, Inc. Gains FDA Clearance for Landmark Phase 2 Trial of Anti-Inflammatory Treatment for Cystic Fibrosis (CF) 2Celtaxsys, Inc. Gains FDA Clearance for Landmark Phase 2 Trial of Anti-Inflammatory Treatment for Cystic Fibrosis (CF) 3
... Calif., March 1, 2012 A consistent theme ... relationship, technological innovation and disease treatment is progression.  ... be seen in healthcare IT, which is expected ... to the healthcare industry.  Companies must maintain a ...
... 1, 2012  In a single bound, Nepean Cancer Care ... for its prostate cancer cases to a dramatically faster ... a technique that is even quicker with Elekta,s new ... treated their first patient with prostate cancer using Integrity ...
Cached Medicine Technology:Frost & Sullivan's Global Healthcare Approach Evolves to Contend with Today's Challenges 2Frost & Sullivan's Global Healthcare Approach Evolves to Contend with Today's Challenges 3Australian Clinic Puts Prostate Cancer Radiation Therapy on Fast Track With Elekta VMAT and Integrity Digital Control System 2Australian Clinic Puts Prostate Cancer Radiation Therapy on Fast Track With Elekta VMAT and Integrity Digital Control System 3
(Date:7/6/2015)... Pittsburgh, PA (PRWEB) , ... July 06, 2015 , ... ... experts in revising national guidelines for thyroid cancer testing to reflect newly available tests ... for when to use and how to interpret thyroid cancer tests is published in ...
(Date:7/6/2015)... (PRWEB) , ... July 06, 2015 , ... ... Practice & Medical Spa industries, announces the return of its complimentary educational ... team of aesthetic medical business leaders creates success for their clients through targeted ...
(Date:7/6/2015)... ... ... Olive Fertility Centre is proud to announce that Olive medical director Dr. ... the department of Family Practice. , “This award is a real honour,” says Dr ... is changing so rapidly and we are also developing new models of patient-centred care ...
(Date:7/6/2015)... , ... July 06, 2015 , ... ... site allows newly-diagnosed cancer patients, caregivers and medical professionals to chat with the ... the same cancer. , “Receiving a cancer diagnosis is often the most traumatic ...
(Date:7/6/2015)... Cutler Bay, Florida (PRWEB) , ... July 06, 2015 , ... ... 22nd facility on Monday, July 6. The newly constructed urgent care center will serve ... medical services. , In addition to being MD Now’s 22nd South Florida location, the ...
Breaking Medicine News(10 mins):Health News:Pitt Scientists Lead Consensus Guidelines for Thyroid Cancer Molecular Tests 2Health News:Pitt Scientists Lead Consensus Guidelines for Thyroid Cancer Molecular Tests 3Health News:Pitt Scientists Lead Consensus Guidelines for Thyroid Cancer Molecular Tests 4Health News:Pitt Scientists Lead Consensus Guidelines for Thyroid Cancer Molecular Tests 5Health News:Acara Partners Announces Complimentary Educational Webinar Series for Cosmetic Medical Practices and MedSpas 2Health News:Acara Partners Announces Complimentary Educational Webinar Series for Cosmetic Medical Practices and MedSpas 3Health News:Olive Fertility Centre Physician Honoured for Teaching 2Health News:Cancer Hope Network Launches Upgraded Website to Support Cancer Patients, Caregivers 2Health News:MD Now Urgent Care Opens its Fourth Miami-Dade County Facility in Cutler Bay 2Health News:MD Now Urgent Care Opens its Fourth Miami-Dade County Facility in Cutler Bay 3
... 20% of recent returnees, but help is available , , ... was known as shell shock. In later military combat ... the emotional scars veterans brought back with them got ... depression, anxiety, substance abuse. , As Americans gather for ...
... Nov. 11 The Grand Opening Celebration of ... 19, from 7:00 until,10:00 p.m. Ocean Blue Plastic ... Miami,s most prestigious addresses. Guests are invited to ... Blue Plastic Surgery while,sampling hors d,oeuvres and sipping ...
... SOUTH PORTLAND, Maine, Nov. 11 Anthem Blue Cross ... nation out of 250 health,insurance plans, according to the ... America,s Best Health Plans 2008. This recognition as one,of ... outstanding overall,performance in clinical care measures, member satisfaction and ...
... 11 In recent independent testing,by ConsumerLab.com ... Plus met standards for ingredient and product ... is available at, http://www.consumerlab.com/results/melatonin.asp ., Schiff ... a sounder,sleep, passed analyses for melatonin and ...
... of, Serious Health Outcomes and Mortality Caused by Fine-Particle ... ... Texas, Nov. 11 A new health impact white paper,conducted by ... at the Harvard School of Public Health,shows that Trane CleanEffects(TM), a ...
... in Patients Increased by 58,Percent From August ... from Arlington,Medical Resources, MALVERN, Pa., Nov. ... of premier market intelligence for the pharmaceutical ... Imaging,s,Cardiolite has 15 percent more market share ...
Cached Medicine News:Health News:Homecoming Veterans Often Face Inner Challenge 2Health News:Homecoming Veterans Often Face Inner Challenge 3Health News:Ocean Blue Plastic Surgery to Open This Month on Brickell Avenue 2Health News:Anthem Blue Cross and Blue Shield in Maine Ranks in Top 6% of all insurers on U.S. News & World Report/National Committee for Quality Assurance Best Health Plans List 2Health News:Anthem Blue Cross and Blue Shield in Maine Ranks in Top 6% of all insurers on U.S. News & World Report/National Committee for Quality Assurance Best Health Plans List 3Health News:Schiff(R) Melatonin Plus Passes ConsumerLab.com Test for Ingredients and Product Quality 2Health News:Schiff(R) Melatonin Plus Passes ConsumerLab.com Test for Ingredients and Product Quality 3Health News:Whole-House Air Cleaner May Help Prevent Asthma Attack, Heart Attack and Stroke 2Health News:Whole-House Air Cleaner May Help Prevent Asthma Attack, Heart Attack and Stroke 3Health News:Radiopharmaceutical Cardiolite has 15 Percent More Market Share than Myoview for September 2008 2
... Microscope with excellent maneuverability. Konan ... weight maintaining high quality. Easy ... by simply changing the adapter. ... has resulted in a sharp ...
... The Optimal temporary implant for use with ... The pupil dilator type 5S is a ... of the pupil during phacoemulsification. It is ... use. Indication: Expansion of the pupil during ...
To maintain the conjunctival cul-de-sacs after enucleation or evisceration without hindering lid closure....
... anatomy of the eyelid for maximum patient ... ease of insertion. Easily removal with forceps. ... offer a slightly smaller bulb for easier ... the same clear and polished silicone as ...
Medicine Products: